Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Irritable Bowel Syndrome, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 38 articles: HTML format

Single Articles

1. LORSCH ZS, Liddle RA
   Mechanisms and clinical implications of gut-brain interactions.
   J Clin Invest. 2026;136:e196346.
   Abstract
   
   
2. ZHANG HM, Zhang Y, Luo GJ, Zhang AX, et al
   Human umbilical cord mesenchymal stem cells alleviated diarrhea-type irritable bowel syndrome by improving intestinal function.
   World J Stem Cells. 2025;17:112100.
   Abstract
   
   
3. SHANG S, Liu Y, Bai QL, Zhang Z, et al
   Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders.
   World J Gastrointest Surg. 2025;17:111359.
   Abstract
   
   
4. VASSALOS CM, Koutelekos I, Vassalou E
   Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
   Adv Exp Med Biol. 2026;1490:181-189.
   Abstract
   
   
5. WU W, Qiu Y, Liang F, Lu W, et al
   Acupuncture and moxibustion in irritable bowel syndrome: a mechanistic exploration from heart rate variability to cardiac metabolism.
   Front Neurol. 2025;16:1716708.
   Abstract
   
   
6. SZURA E, Poniewierka E
   Impact of physical activity and selected relaxation techniques on the quality of life of female patients with irritable bowel syndrome.
   Prz Gastroenterol. 2025;20:439-442.
   Abstract
   
   
7. SINGH A, Singh R
   The gastrointestinal endothelin system: receptors, cellular actions, and involvement in gastrointestinal disorders.
   Prz Gastroenterol. 2025;20:372-381.
   Abstract
   
   
8. BALLENA-CAICEDO J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Valladares-Garrido MJ, et al
   Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
   Front Med (Lausanne). 2025;12:1714085.
   Abstract
   
   
9. CHIU YT, Lee FJ, Kuo CY, Yang PC, et al
   The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot Study.
   JGH Open. 2025;9:e70329.
   Abstract
   
   
10. LEPCZYNSKA M
    The interplay between Blastocystis and human gut microbiota.
    Ann Parasitol. 2025;71:171-184.
    Abstract
    
    
11. CHAVHAN PKB, Sayeed MS, Saiyad SS, Shah MN, et al
    Lactose Intolerance in Irritable Bowel Syndrome: Prevalence, Subtype Correlations, and Clinical Predictors in an Indian Cohort.
    Cureus. 2025;17:e97697.
    Abstract
    
    
12. PUSHADAPU VVSK, Srikar G
    Development and evaluation of chitosan-xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations.
    Daru. 2025;34:6.
    Abstract
    
    
13. POPA IV, Dranga M, Nedelciuc O, Mihai C, et al
    Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review.
    J Gastrointestin Liver Dis. 2025;34:510-514.
    Abstract
    
    
14. MOU JJ, Xu L, Luo YF, Tao QF, et al
    Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis.
    J Gastrointestin Liver Dis. 2025;34:503-509.
    Abstract
    
    
15. DU Y, Xu H, Xiong J, Wang Z, et al
    Tracing Evolution of Hotspots and Frontiers: A Bibliometric Exploration of Acupuncture Therapy in Irritable Bowel Syndrome.
    J Multidiscip Healthc. 2025;18:8133-8152.
    Abstract
    
    
16. SAHU SK, Nath P, Mallick B, Praharaj D, et al
    Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.
    Cureus. 2025;17:e97523.
    Abstract
    
    
17. GUAGNOZZI D, Gonzalez-Castro AM, Zabana Y, Fernandez-Banares F, et al
    Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.
    United European Gastroenterol J. 2026;14:e70156.
    Abstract
    
    
18. MIDENFJORD I, Khadija M, Sundelin E, Trindade IA, et al
    Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
    United European Gastroenterol J. 2026;14:e70157.
    Abstract
    
    
19. CAI E, Kouznetsova VL, Tsigelny IF
    Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection.
    Metabolites. 2025;15:801.
    Abstract
    
    
20. AL-MADHAGI H
    A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome.
    Biomed Res Int. 2025;2025:8227229.
    Abstract
    
    
21. SUN F, Li H, Gong B, Hui S, et al
    Investigating the Causal Relationship and Shared Genetic Basis Between Major Depression Disorder and Eight Types of Gastrointestinal Diseases.
    Genet Res (Camb). 2025;2025:6931243.
    Abstract
    
    
22. HSU LH, Chou YP, Shen TL, Wieczorek D, et al
    Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis.
    Virulence. 2026;17:2609407.
    Abstract
    
    
23. TACK C, Van den Houte K, Besard L, Capiau L, et al
    A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.
    BMC Gastroenterol. 2025 Dec 23. doi: 10.1186/s12876-025-04494.
    Abstract
    
    
24. DOWRICK JM, Roy NC, Carco C, James SC, et al
    Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
    Gut Microbes. 2026;18:2604871.
    Abstract
    
    
25. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    Abstract
    
    
26. PROSPERO L, Riezzo G, Laselva G, D'Attoma B, et al
    Somatization, psychological distress, and quality of life across fibromyalgia, irritable bowel syndrome, and their comorbid phenotype: a cross-sectional clinical comparison.
    Front Psychol. 2025;16:1709017.
    Abstract
    
    
27. ELKALLA MA, Ali YG, Ewais MM, Taha AS, et al
    Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07861.
    Abstract
    
    
28. VON MUHLENBROCK C, Aronsohn F, Quera R, Madrid AM, et al
    The role of dietary fiber in the gastrointestinal tract: when, how and why?
    Best Pract Res Clin Gastroenterol. 2025;79:102080.
    Abstract
    
    
29. BIESIEKIERSKI JR
    Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity.
    Best Pract Res Clin Gastroenterol. 2025;79:102086.
    Abstract
    
    
30. BERSCHBACK M, Abber S, Smith J, Staller K, et al
    Avoidant/restrictive food intake disorder in disorders of gut-brain interaction.
    Best Pract Res Clin Gastroenterol. 2025;79:102078.
    Abstract
    
    
31. VAN DEN HOUTE K
    Dietary approaches in functional bowel disorders.
    Best Pract Res Clin Gastroenterol. 2025;79:102077.
    Abstract
    
    
32. ZHENG NS, Bar N, Kuo B, Staller K, et al
    Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System.
    Aliment Pharmacol Ther. 2026;63:294-298.
    Abstract
    
    
33. KHASAWNEH M, Goodoory VC, Ng CE, Ford AC, et al
    Stability of Classification Systems for Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Dec 25. doi: 10.1111/apt.70503.
    Abstract
    
    
34. ALSAKARNEH S, Al Ta'ani O, Mahmoud MY, Syn WK, et al
    Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.
    Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506.
    Abstract
    
    
35. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
    Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
    Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
    Abstract
    
    
36. CRISTOFORI F, Calabrese FM, De Angelis M, Francavilla R, et al
    Data over doubt: Clarifications on calcium butyrate efficacy in pediatric irritable bowel syndrome.
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70326.
    Abstract
    
    
37. VERMEIJDEN NK, Gordon M, Benninga M, Vlieger A, et al
    Analysis of "Calcium butyrate efficacy in pediatric irritable bowel syndrome".
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70328.
    Abstract
    
    
38. HAMBERG LEVEDAHL K, Carlson M, Nilsson GP, Jakobsson Larsson B, et al
    Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.
    Scand J Gastroenterol. 2025 Dec 21:1-10. doi: 10.1080/00365521.2025.2604778.
    Abstract